Triple receptor agonist (Lancaster University)

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameTriple receptor agonist (Lancaster University)
Drug Alias NameGLP-1/GIP/glucagon receptor agonists (Lancaster University)glucagon-like peptide-1/gastric inhibitory polypeptide/glucagon receptor agonists (Lancaster University)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsGlucagon receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsGlucagon receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLancaster University
China Registration ClassN/A

Develop Information

Active CompaniesLancaster UniversityShanxi Medical University
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A